SHENZHEN, China, Dec 12, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 10, 2014.
At the meeting, Mindray shareholders voted to re-elect incumbent directors Li Xiting and Kern Lim, each to serve a three-year term. Mindray's shareholders did not re-elect Peter Wan as a director.
In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014.
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit: www.mindray.com.
For investor and media inquiries, please contact:
In China: Cathy Gao Mindray Medical International Limited Tel: +86-755-8188-8023 Email: email@example.com
In the U.S: Hoki Luk Western Bridge, LLC Tel: +1-646-808-9150 Email: firstname.lastname@example.org
SOURCE Mindray Medical International Limited